含有阿利吉仑、氢氯噻嗪和叶酸的药物组合物及其用途制造技术

本发明专利技术涉及一种含有阿利吉仑、氢氯噻嗪和叶酸的药物组合物。该药物组合物包含药用剂量的阿利吉仑、药用剂量的氢氯噻嗪、药用剂量的叶酸和药剂学上可接受的载体。本发明专利技术还涉及该药物组合物在制备用于预防、治疗或延缓高血压、高血压引起的靶器官损害的药物中的用途，本发明专利技术还涉及该药物组合物在制备用于降低高血压引起的心脑血管事件危险性的药物中的用途。属于药学领域。通过本发明专利技术的实施，提供给患者这种特定用途的药物组合物可以提高患者依从性，使患者服药方便，降低医疗费用，具有较好市场前景。

Pharmaceutical composition containing aliskiren, hydrochlorothiazide and folic acid and use thereof

The present invention relates to a pharmaceutical composition containing aliskiren, hydrochlorothiazide, and folic acid. The pharmaceutical composition comprises a pharmaceutical dose of aliskiren, a pharmaceutical dose of hydrochlorothiazide, a pharmaceutically acceptable dose of folic acid, and a pharmaceutically acceptable carrier. The invention also relates to the use of drugs of the pharmaceutical composition in preparing for the prevention and treatment of target organ damage caused by hypertension, hypertension or delay in, the invention also relates to the pharmaceutical composition in preparing medicament for reducing cardiovascular events caused by hypertension risk in. It belongs to the field of pharmacy. Through the implementation of the present invention, the specific drug composition provided to the patient can improve patient compliance, make the patient easy to take medicine and lower medical expenses, and has a better market prospect.

【技术实现步骤摘要】

【技术保护点】
一种药物组合物，包括：　（１）药用剂量的阿利吉仑；　（２）药用剂量的氢氯噻嗪；　（３）药用剂量的叶酸；及　（４）药剂学上可接受的载体。

【技术特征摘要】

【专利技术属性】
技术研发人员：陈明侠，王文艳，陈光亮，徐希平，
申请(专利权)人：北京奥萨医药研究中心有限公司，深圳奥萨医药有限公司，
类型：发明
国别省市：11[中国|北京]